In a substantial number of cases — some two billion, in fact — the tuberculosis bacteria (Mycobacterium tuberculosis) isn’t active at all. Instead, it hides inside cell aggregates, latent and persistent, waiting to break out. Now, scientists have discovered several first-in-class compounds that target these hidden infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.